128 related articles for article (PubMed ID: 4147511)
21. Potential value of penfluridol and pipothiazine palmitate.
Gallant DM
Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
[No Abstract] [Full Text] [Related]
22. Penfluridol (R 16341) as a maintenance therapy in chronic psychotic patients: a double-blind clinical evaluation.
Roelofs GA
Acta Psychiatr Scand; 1974; 50(2):219-24. PubMed ID: 4604881
[No Abstract] [Full Text] [Related]
23. Pipotiazine palmitate: a new depot neuroleptic.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1975 Mar; 17(3):276-80. PubMed ID: 236151
[No Abstract] [Full Text] [Related]
24. Psychological medicine. Schizophrenia and related paranoid psychoses.
Kennedy PF
Br Med J; 1975 May; 2(5965):257-60. PubMed ID: 236808
[No Abstract] [Full Text] [Related]
25. Clinical evaluation of a new depot neuroleptic. A pilot study with pipotiazine undecylenate (19.551 R.P.).
Ahlfors UG; Katila O
Acta Psychiatr Scand Suppl; 1973; 241():43-9. PubMed ID: 4147510
[No Abstract] [Full Text] [Related]
26. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
Malm U; Perris C; Rapp W; Wedrén G
Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
[No Abstract] [Full Text] [Related]
27. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
Kline NS; Mason BT; Winick L
Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
[No Abstract] [Full Text] [Related]
28. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Kulkarni AS
Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
[No Abstract] [Full Text] [Related]
29. [Psychopharmacologic study of 8909 RP (Neuleptil) by Wittenborn's Psychiatric Status Rating Scale].
Beauseigneur-Nuyts T; Vallet R; Le Viet MQ
Encephale; 1964; 53(3):405-14. PubMed ID: 4388707
[No Abstract] [Full Text] [Related]
30. Specific indications for different classes of phenothiazines.
Hollister LE; Overall JE; Kimbell I; Pokorny A
Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
[No Abstract] [Full Text] [Related]
31. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
Vandecasteele AJ; Vereecken JL
Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
[No Abstract] [Full Text] [Related]
32. [Discriminative study of the effect of a psychotropic drug by use of B.P.R.S. cards].
Sizaret P; Degiovanni A; Penaud J
Encephale; 1972; 61(4):316-24. PubMed ID: 4145384
[No Abstract] [Full Text] [Related]
33. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia.
Lahti AC; Weiler MA; Corey PK; Lahti RA; Carlsson A; Tamminga CA
Biol Psychiatry; 1998 Jan; 43(1):2-11. PubMed ID: 9442338
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH
Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022
[TBL] [Abstract][Full Text] [Related]
35. New drug offers hope for people with schizophrenia.
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
[No Abstract] [Full Text] [Related]
36. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
Hollister LE
Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
[No Abstract] [Full Text] [Related]
37. Risperidone: clinical development: north American results.
Marder SR
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():92A-93A. PubMed ID: 1379883
[TBL] [Abstract][Full Text] [Related]
38. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
39. Piperacetazine and chlorpromazine: a comparison.
Johnson AC; Kulkarni AS
Am J Psychiatry; 1973 May; 130(5):603-5. PubMed ID: 4144711
[No Abstract] [Full Text] [Related]
40. A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.
Johnston RE; Niesink F
J Int Med Res; 1979; 7(3):187-93. PubMed ID: 37133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
